Encouraged by these reports, in the present study, we first investigated the effect of AKI on cognitive performance of rats and potential neuroprotective impact of EPO to suggest a possible therapeutic intervention in clinical practice, then to determine the possible molecular mechanism responsible for AKI-induced alterations of memory function, we examined BDNF expression in the hippocampus of the experimental groups. This evidence concerns the gene EPO and acute kidney injury.